Intraocular Methotrexate in Ocular Diseases Other Than Primary Central Nervous System Lymphoma

American Journal of Ophthalmology

Volumn 142, Issue 5, 2006, Pages 883-885

  Hardwig, Paul W ^a   Pulido, Jose S ^a   Erie, Jay C ^a   Baratz, Keith H ^a   Buettner, Helmut ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CORTICOSTEROID; METHOTREXATE;

ADULT; AGED; ARTICLE; CATARACT; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORNEA DISEASE; DIABETIC RETINOPATHY; DISEASE ACTIVITY; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; ENDOPHTHALMITIS; EYE DISEASE; FEMALE; HUMAN; LYMPHOMA; MALE; NERVOUS SYSTEM TUMOR; PRIORITY JOURNAL; RETINA MACULA CYSTOID EDEMA; RETINA MACULOPATHY; RETROSPECTIVE STUDY; VISUAL ACUITY; VISUAL IMPAIRMENT; VITREORETINOPATHY; VITREOUS HEMORRHAGE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS; LYMPHOMA; MALE; METHOTREXATE; MIDDLE AGED; RETINITIS; RETROSPECTIVE STUDIES; UVEITIS; VISUAL ACUITY; VITREORETINOPATHY, PROLIFERATIVE; VITREOUS BODY;

EID: 33750059779     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2006.06.002     Document Type: Article

References (6)

1. Samson C.M., Waheed N., Baltatzis S., and Foster C.S. Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients. Ophthalmology 108 (2001) 1134-1139
2. Fishburne B.C., Wilson D.J., Rosenbaum J.T., and Neuwelt E.A. Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma. Arch Ophthalmol 115 (1997) 1152-1156
3. Smith J.R., Rosenbaum J.T., Wilson D.J., et al. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology 109 (2002) 1709-1716
4. Deng S.X., Penland S., Gupta S., et al. Methotrexate reduces the complications of endophthalmitis resulting from intravitreal injection compared with dexamethasone in a rabbit model. Invest Ophthalmol Vis Sci 47 (2006) 1516-1521
5. Velez G., Yuan P., Sung C., et al. Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma. Arch Ophthalmol 119 (2001) 1518-1524
6. Jarus G., Blumenkranz M., Hernandez E., and Sossi N. Clearance of intravitreal fluorouracil. Normal and aphakic vitrectomized eyes. Ophthalmology 92 (1985) 91-96